Walleye Capital LLC Ars Pharmaceuticals, Inc. Comm Transaction History
Walleye Capital LLC
- $24 Billion
- Q3 2025
A detailed history of Walleye Capital LLC transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Walleye Capital LLC holds 36,862 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.